Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| "Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias" | ApoPharma | Ongoing | Deferiprone | 3b | LA38-EXT | ACH |
| Lessening Organ Dysfunction with VITamin C | KAIMRC | Completed | ascorbic acid injection | 3 | CT19/022/R | King Abdulaziz Medical City NG (Riyadh) |
| Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control trial | King Fahad Hospital of the University | Completed | Ketamine | 3 | 2016-01-042 -Version 02 | KFUH |
| Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled | King Abdullah Medical City, Makkah | Completed | Dexmedetomidine | 2 | version 4 | KAMC |
| Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled | King Abdullah Medical City, Makkah | Completed | Dexmedetomidine | 2 | version 4 | KAMC |
| International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan | Sanofi | Terminated | Lixisenatide | 3 | LPS14410 | KKUH |
| Inflammatory Regulation Effect of NAC on COVID-19 Treatment | KKUH | Ongoing | N-acetylcysteine | 3 | E-20-4934 | King Khalid University Hospital (Riyadh) |
| Inflammatory Regulation Effect of NAC on COVID-19 Treatment | KKUH | Ongoing | N-acetylcysteine | 3 | E-20-4934 | King Khalid University Hospital (Riyadh) |
| Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease. | Celgene | Ongoing | Ozanimod HCl | 3 | RPC01-3201 | KAUH-J |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | SWOG (Southwest Oncology Group) | Ongoing | Ibrutinib | 3 | A051301 | KFSH&RC-R |